Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes
1. Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related serious adverse events ...
Tag: claudication
![Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Taxus_stent_FDA-e1607803635904-350x250.jpg)
No increase in mortality with paclitaxel-coated devices among patients with femoropopliteal disease
1. There was no significant increase in mortality between the paclitaxel-coated and control devices in both the intention-to-treat and as-treated ...
Best endovascular treatment superior to vein bypass for patients with chronic limb ischemia requiring infrapopliteal revascularization
1. Major amputation and all-cause mortality were higher in the vein bypass group compared to the best endovascular treatment group. ...
Home-based walking program an effective treatment for peripheral artery disease
Image: PD 1. Home-based therapy intervention that provides a support structure via a group program increases the distance and speed ...
